Skip to main content

Table 1 Baseline characteristics of the study population, overall and by FTR development grade

From: Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up

  Overall (N = 134) RTF (N = 40) No FTR (N = 94) Mild FTR (N = 8) Moderate FTR (N = 25) Severe FTR (N = 7) p value for trend
Age, y 59.7 ± 11.5
[59;30–94]
62.4 ± 11.5
[62;37–84]
59.3 ± 12.4
[59;30–94]
55.3 ± 11.9
[55;37–78]
61.0 ± 8.6
[61; 48–84]
65.4 ± 5.2
[66;55–72]
 < 0.0001X
Age, > 65y, n (%) 43 (32.1) 14 (35) (30.9) 29 1 (12.5) 8 (32) 5 (71.4) 0.39
Male, n (%) 105 (78.4) 30 (75) 75 (71.4) 7 (87.5) 18 (72) 5 (71.4) 0.23
Clinical history
Smoker, n (%) 75 (56) 20 (50) 51 (54.3) 4 (50) 14 (56) 6 (85.7) 0.5
Obesity, n (%) (25.4) 34 12 (30) (23.4) 22 (0) 0 (36)9 (42.9)3 0.42
Hypertension, n (%) 68 (50.7) 19 (47.5) 28 (29.8) 0 (0) 4 (16) 2 (28.6) 0.1
Dyslipidemia, n (%) 95 (70.9) 33 (82.5) 66 (70.2) 6 (75) 19 (76) 4 (57.1) 0.79
Chronic renal failure, n (%) 6 (4.6) 2 (5.0) 5 (5.5) 0 (0) 1 (4) 0 (0) 0.88
Diabetes mellitus, n (%) 52 (38.8) 18 (45) 38 (40.4) 3 (37.5) 7 (28) 4 (57.1) 0.5
PVD, n (%) 7 (5.2) 4 (10) 5 (5.3) 0 (0) 1 (4) 1 (14.3) 0.72
AF, n (%) 26 (19.4) 12 (30) 18 (19) 2 (25) 6 (24) 0 (0) 0.76
CABG, n (%) 6 (4.5) 2 (5.0) 3 (3.2) 1 (12.5) 1 (4) 1 (14.3) 0.28
Killip class, n (%) 0.81
1 112 (83.6) 34 (85) 79 (84) 7 (87.5) 19 (76) 7 (100)  
2 1 (0.7) 1 (2.5) 1 (1.1) 0 (0) 0 (0) 0 (0)  
3 7 (5.2) 3 (7.5) 3 (3.2) 0 (0) 4 (16) 0 (0)  
4 14 (10.4) 2 (5.0) 11 (11.7) 2 (8) 2 (8) 0 (0)  
Peak total CPK, mean 1925 1825 1587 1927 2688 3815 0.68
Peak TnI, mean 2713 2302 2531 2612 3091 3927 0.01
IRA 0.79
LM 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)  
LAD 64 (47.8) 19 (47.5) 45 (47.9) 4 (50) 10 (40) 5 (71.4)  
CX 4 (3) 2 (5.0) 2 (2.1) 1 (12.5) 1 (40) 0 (0)  
RCA 45 (36) % 14 (35) 31 (33) 2 (25) 11 (44) 1 (14.3)  
Other 21 (15.7) 5 (12.5) 16 (17) 1 (12.5) 3 (12) 1 (14.3)  
Multi-vessels CAD, n (%) 79 (59) 26 (65) 53 (56.4) 6 (75) 16 (64) 4 (57.1) 0.71
Successful PCI, n (%) Ψ 128 (91) 30 (75) 92 (97.9) 8 (100) 17 (68) 5 (71.4)  < 0.0001
  1. PVD indicates Peripheral Vascular disease; AF, Atrial Fibrillation; CABG, Coronary artery bypass grafting; CPK, Creatinine phosphokinase; TnI, Troponin I; IRA, Infarct related artery; LM, left main; LAD, left descending artery; CX, Circumflex artery; RCA, Right coronary artery; CAD, coronary artery disease; PCI, percutaneous coronary intervention
  2. ΨDefined as successfully performed balloon dilatation or stent implantation
  3. XCochrane-Armitage progression test